Key Takeaways HUM is expected to post a sharp year-over-year earnings decline in Q4 despite revenue growth of 9.2%.Humana's premium and service revenues are rising, but insurance and investment income are declining.HUM's medical membership is projected to drop 7.6% year over year, while the benefits expense ratio worsens.Humana Inc. (HUM) is set to report fourth-quarter 2025 results on Feb. 11, 2026, before the opening bell. For the to-be-reported quarter, the Zacks Consensus Estimate projects a loss of $4. ...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana is investing in a new program with Jefferson Community and Technical College to strengthen and support Kentucky's nursing workforce. In announcing the launch of the Humana Scholars program, Humana joins the Kentucky Community and Technical College System (KCTCS) network of Education First Employers, partnering with the system's Louisville campus, Jefferson. Humana is investing a total of $125,000 in the Humana Scholars program, which includes two compone. ...

Humana Inc. (NYSE:HUM) is one of the noteworthy S&P 500 stocks Jim Cramer highlighted. Cramer highlighted what caused an instant sell-off in companies like Humana and others that had exposure to Medicare Advantage. The Mad Money host stated: The third worst performer in the S&P last month was Humana, the managed care company with a lot of exposure to Medicare Advantage. These are healthcare plans for senior citizens that are subsidized by the federal government. Last Monday night, the Centers for Medicare ...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), a health and well-being company focused on helping people live their healthiest lives, today released its latest Value-Based Care By the Numbers Report. The findings show that value-based care helps Medicare Advantage patients receive more personalized, preventive care while improving their overall health experience. Every path in value-based care leads to one goal: helping people achieve their best health." -Alex Ding, M.D., Deputy Chief Medical Of ...

ENGLEWOOD, Colo., Feb. 4, 2026 /PRNewswire/ -- Zynex, Inc. (ZYXIQ), an innovative medical device company specializing in non-invasive medical devices for pain management, announced it has for the first time entered into a provider agreement with Humana Inc. (NYSE: HUM), effective February 1, 2026. About Zynex, Inc. Zynex, founded in 1996, is a pain management device manufacturer and distributor. For additional information, visit: www.zynex.com. Investor Relations Contact: Vikram Bajaj, CFO E-mail: [email pr ...

UnitedHealth Group Inc. (NYSE:UNH), CVS Health Corp. (NYSE:CVS), and Humana Inc. (NYSE:HUM) declined last week, but while investors focused on the Donald Trump administration’s proposed near-zero increase in Medicare Advantage, another major regulatory threat emerged late Thursday that could squeeze the industry’s profits from the other end. Shining A Light On ‘Ghost’ Billions The U.S. Department of Labor (DOL), on Jan. 29, issued a landmark proposed regulation demanding “radical transparency” from Pharma ...

Core Insights - Humana has launched Agent Assist, an AI-driven support tool developed in collaboration with Google Cloud to enhance member advocacy in health insurance [1][2] - The initiative signifies a broader trend of AI adoption in healthcare operations and customer service [2][6] Group 1: Tool Features and Functionality - Agent Assist utilizes Google Cloud technologies, including Vertex AI and Gemini, to support over 20,000 member advocates across Humana's service centers, handling millions of inquiries annually [3] - The tool generates real-time call summaries, surfaces relevant information during interactions, and provides guidance for compliance and accurate responses [3] - A human-in-the-loop approach is implemented, allowing member advocates to maintain decision-making authority while AI aids in information retrieval and reduces manual workload [4] Group 2: Implementation and Future Plans - Member advocates began using Agent Assist in October, with a full rollout expected across service centers within the year [5] - The tool will integrate into existing call center systems and will undergo ongoing performance and compliance reviews [5] - This initiative is part of Humana's broader digital transformation strategy aimed at improving member experiences through responsible AI use [5] Group 3: Industry Trends - Humana's move aligns with industry trends of integrating AI and generative AI into customer service and healthcare support functions [6] - A Google Cloud study indicates that 44% of executives in healthcare and life sciences have AI agents in production, with nearly half of organizations allocating over 50% of future AI budgets to these agents [7]

Humana introduces Agent Assist to help member advocates deliver faster, more personalized support, enabled by an expanded partnership with Google Cloud "Our collaboration with Humana is a blueprint for the future of healthcare—where technology doesn't replace the human element, but radically enhances it," said Chris Sakalosky, vice president, Strategic Industries, Google Cloud. "By integrating Gemini Enterprise for CX, we're giving Humana's advocates an agent that handles the complexity of benefits in the b ...

1. 艾瑞特投行将 Shopify（SHOP）的评级从中性上调至买入，目标价从 166 美元上调至 175 美元。 该机构认为，该股近期走弱后，估值已具备吸引力。 2. 威廉・布莱尔投行在帕兰提尔（PLTR）发布财报前，将其评级从市场表现上调至跑赢大盘，暂未 给出目标价。该股此前暴跌 30%，该机构称估值优势是此次上调评级的核心原因。 3. BTIG 投行将麦当劳（MCD）的评级从中性上调至买入，目标价定为 360 美元。该机构表示，对 麦当劳加盟商的调研显示，其性价比及促销策略的调整正持续推动到店客流量增长。 4. 摩根大通将欧特克（ADSK）的评级从中性上调至增持，目标价维持 319 美元不变。该机构对工 业软件板块标的评级进行调整，称垂直领域软件即服务行业的基本面分化，使其投资判断发生转 变。 5. 摩根大通将丘奇 & 德怀特（CHD）的评级从减持上调至中性，目标价从 92 美元上调至 100 美 元。该行认为，丘奇 & 德怀特的业务组合调整后，将实现更亮眼的销售增长。 1. 摩根大通将百思买（BBY）的评级从增持下调至中性，目标价从 99 美元大幅下调至 76 美元。该 机构预计，百思买第四季度的业绩 ...

Core Viewpoint - Humana Inc. is experiencing stock price fluctuations and mixed signals from analysts and investors, indicating a complex outlook for the company in the health insurance sector [1][2][5]. Group 1: Analyst Insights - Morgan Stanley has set a price target of $174 for Humana, suggesting a potential decrease of approximately -10.86% from the current trading price of $195.20 [1][5]. - The stock has shown volatility, with a trading range today between $192.40 and $197.34, and over the past year, it has reached a high of $315.35 and a low of $191.39 [4]. Group 2: Investor Activity - Tejara Capital Ltd has acquired 7,200 shares of Humana, valued at around $1.87 million, indicating confidence in the company's long-term potential despite a slight decrease in stock price [2][5]. - Other hedge funds, such as Elevation Point Wealth Partners LLC and Mather Group LLC, have made new investments in Humana, with positions valued at approximately $32,000 and $34,000, respectively [3][5]. - Private Wealth Management Group LLC increased its holdings in Humana by 47.5% in the third quarter, now owning 149 shares valued at $39,000 [3]. Group 3: Market Metrics - Humana's market capitalization is approximately $23.48 billion, with a trading volume of 3,220,371 shares on the NYSE [4].